Paralogue-Selective Degradation of the Lysine Acetyltransferase EP300

• Xuemin Chen,
• McKenna C. Crawford,
• Ying Xiong,
• Anver Basha Shaik,
• Kiall F. Suazo,
• Ludwig G. Bauer,
• Manini S. Penikalapati,
• Joycelyn H. Williams,
• Kilian V. M. Huber,
• Thorkell Andressen,
• Rolf E. Swenson,
• Jordan L. Meier

Affiliations

Xuemin Chen

Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States

McKenna C. Crawford

Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States

Ying Xiong

Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States

Anver Basha Shaik

Chemistry and Synthesis Center, National Heart Lung and Blood Institute, Rockville, Maryland, United States

Kiall F. Suazo

Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States

Ludwig G. Bauer

Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.

Manini S. Penikalapati

Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States

Joycelyn H. Williams

Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States

Kilian V. M. Huber

Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.

Thorkell Andressen

Protein Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, Maryland, United States

Rolf E. Swenson

Chemistry and Synthesis Center, National Heart Lung and Blood Institute, Rockville, Maryland, United States

Jordan L. Meier

Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States